Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CAD

Clinical trial NCT03693560 · COMPLETED

Trial details

NCT number: NCT03693560
Sponsor: Damanhour University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Artery Disease Diabetes Mellitus, Type 2

Start date: 2018-10-08
Primary completion: 2019-09-10
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.